|
||||||||||||
|
||||||||||||
|
||||||||||||
|
||||||||||||
|
||||||||||||
|
||||||||||||
Aims of the study:
Sacral nerve stimulation is a succuessful treatment
for chronic voiding dysfunction. To objectivate the stimulator
effect on the urethral sphincter and other pelvic floor muscles,
a concentric needle EMG study was performed.
Methods:
In five patients, concentric needle EMG was
performed before and after sacral nerve stimulation. In three
patients this was done during the subchronic percuatanous
testing phase. In two other patients the study was done after
definitive implant. In these patients the clinical effect
was not satisfying and lead malpositioning was suspected,
but could not be proven by X-ray or clinical testing.
Results:
In all patients a stimulation artefact could
be seen om the EMG.This artefact was not only present in the
external urethral sphincter but also in other muscles which
were not part of the same myotome (volume conduction).
Conclusion:
1) This effect on interdischarge variability
can be useful to determine wether the stimulator lead is placed
in the best possible location.
It can help to objectivate the stimulator effects
in patients without clinical improvement of their voiding
problems despite correct anatomical positioning of the lead.
2) The central control of the firing rate variability
is poorly understood. Possibly the electric discharges produced
by the stimulator interfere directly at the medullar level
with the "pre-programmed" firing pattern, possibly
by altering the times course of the repolarisation (after-hyperpolarization)
phase of the spinal motor neurons, thus leading to irregular
discharge rates. Additional influence upon the descending
volleys from the pontine micturition/storage centers is also
possible.
1) Naunyn-Schmiedeberg’s Arch Pharmacol 347:624-629,1993.
2) Histopathology 23:519-525,1993.